#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
In this study, it was discovered that during extreme long-distance running, levels of anandamide and another endocannabinoid, 2-AG, significantly increase in the body. These cannabis-like molecules are known to play a role in pain regulation, inflammation, and mood. This finding may have implications for understanding the body’s natural response to physical stress and potentially the effects of cannabis on athletic performance or recovery. Clinicians should be aware of this potential interaction when managing patients who engage in endurance sports and use cannabis products.
🏃♂️ Intriguing findings suggest a significant surge in our body’s cannabis-like molecules, anandamide and 2-AG, during extreme long-distance running. (1) This increase is not limited to the onset of exercise but persists throughout. (2) These endocannabinoids are known to interact with the same receptors as cannabis, potentially influencing pain perception, inflammation, and energy balance. (3) However, it’s crucial to acknowledge that this research does not directly translate to implications for clinical cannabis use in patients. Instead, a better understanding of these endocannabinoids could lead to novel therapeutic strategies for managing exercise-induced pain and inflammation. (4) Further studies are needed to confirm these findings and explore potential confounders, such as the role of other exercise-related hormones and metabolites.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
